Stryker Corp (SYK)

141.28
1.40 1.00
NYSE : Health Care
Prev Close 142.71
Open 142.30
Day Low/High 141.00 / 142.64
52 Wk Low/High 106.48 / 148.84
Volume 114.23K
Avg Volume 1.14M
Exchange NYSE
Shares Outstanding 374.06M
Market Cap 53.51B
EPS 4.40
P/E Ratio 31.93
Div & Yield 1.70 (1.20%)

Latest News

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Stryker Corporation

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Stryker Corporation

Levi & Korsinsky announces it has commenced an investigation of Stryker Corporation ("Stryker" or the "Company") (NYSE: SYK) concerning possible violations of federal securities laws.

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

This week's bullish and bearish reversal patterns.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Stryker Corporation And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Stryker Corporation And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Stryker Corporation ("Stryker" or the "Company") (NYSE: SYK) concerning possible violations of federal securities laws.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Stryker Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Stryker Corporation

Levi & Korsinsky announces it has commenced an investigation of Stryker Corporation ("Stryker" or the "Company") (NYSE: SYK) concerning possible violations of federal securities laws.

Don't Get Out of Joint

Don't Get Out of Joint

Demand for artificial joints is growing, and Zimmer Biomet is a good way to play the demographic trend.

Stryker Becomes #124 Most Shorted S&P 500 Component, Replacing Salesforce.com

The most recent short interest data has been released for the 07/31/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Zimmer Biomet: Cramer's Top Takeaways

Zimmer Biomet: Cramer's Top Takeaways

Jim Cramer says sometimes a company can have a great long-term story, but management fails to deliver.

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Market Stands at a Make-Or-Break Level: Cramer's 'Mad Money' Recap (Monday 7/17/17)

Jim Cramer says the earnings results we get this week will determine where stocks are headed for the rest of the quarter.

Stryker Corp. Moves Up In Market Cap Rank, Passing General Motors

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Stryker Corp. has taken over the #100 spot from General Motors Co.

Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal

Analyst Says Rival Bidder Could Emerge for Novadaq After Stryker Deal

The fluorescence imaging technology company has agreed to sell to Stryker for $11.75 per share.

Stryker Corp. Stock Climbs Following Acquisition of NOVADAQ Technologies

Stryker Corp. Stock Climbs Following Acquisition of NOVADAQ Technologies

The medical device maker will pay $701 million for NOVADAQ.

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra's Massive Run-Up Expected to Continue as J&J's Surgical Business Joins the Fold

Integra announced in February its intent to acquire Codman Neurosurgery from Johnson & Johnson.

Stryker Becomes #118 Most Shorted S&P 500 Component, Replacing Ameren

The most recent short interest data has been released for the 05/15/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Stryker Moves Up In Analyst Rankings, Passing Whirlpool

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Stryker Corp. has taken over the #128 spot from Whirlpool Corp , according to ETF Channel.

Cramer: These Sectors Look Bullish (Part III)

Cramer: These Sectors Look Bullish (Part III)

From Abbott Labs to Wynn, these names rate checking out.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

The New #104 Most Shorted S&P 500 Component: Stryker

The most recent short interest data has been released for the 04/13/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Market Recon: We Need a Deal to Keep the Federal Government Humming

Market Recon: We Need a Deal to Keep the Federal Government Humming

Some kind of spending deal will have to be in place by Saturday in order to avoid the mayhem.

Cramer: We Have Nothing to Distinguish the Stocks Right Now

Cramer: We Have Nothing to Distinguish the Stocks Right Now

We know that we are in the era when index managers are ascendant.

Market Recon: Health Care Reform Football Bounces Around on Dangerous Turf

Market Recon: Health Care Reform Football Bounces Around on Dangerous Turf

Is this reform about to rise from the dead, like a movie monster that just won't die?

Stryker Becomes #75 Most Shorted S&P 500 Component, Replacing Bed, Bath & Beyond

The most recent short interest data has been released for the 02/28/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Cramer: Top 10 Bull Markets Right Now (Part 1)

Cramer: Top 10 Bull Markets Right Now (Part 1)

Bull market number one, perhaps of all time: the financials.

Cramer: Top 10 Bull Markets Right Now

Cramer: Top 10 Bull Markets Right Now

Bull market number one, perhaps of all time: the financials.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

TheStreet Quant Rating: A (Buy)